CosmosID obtains French CIR Agreement

10 March 2020by Manoj Dadlani

Fresh croissants with wafer thin crusts, a glass of lovely Merlot, or strolls along the Seine in Paris are among the many pleasant associations one might have when thinking of La France. We’d like to propose another one: Saving a hefty 30% on your research spend thanks to the French authorities.

We are proud to announce that CosmosID has been awarded a Research Tax Credit (CIR / Credit Impots Research) agreement with the French government.

Our French customers may under this agreement be eligible for a 30% research tax credit. The agreement between CosmosID and the Ministère de l’Enseignement Supérieur de la Recherche et de l’Innovation is valid for the years 2020 to 2021 and permits clients to obtain a corporate tax refund on R&D expenses they incur when working with CosmosID.

For more information on the Research Tax Credit (CIR / Credit Impots Research) please visit

Don’t hesitate to get in touch with us if you’d like to find out more.


Manoj Dadlani

Mr. Manoj Dadlani serves as Chief Executive Officer at CosmosID, Inc., the Maryland based provider of industry-leading solutions for unlocking the microbiome. Previously, Mr. Dadlani served as a partner at Applied Value Group, a management consulting and investment firm, and was co-founder and CEO at Rasa Industries, Ltd., a leading beverage manufacturing company. Mr. Dadlani has substantial experience in strategy, M&A, supply chain management, product development, marketing and business development. Mr. Dadlani received his bachelor’s and master’s degrees in Biological Engineering from Cornell University. Services offered by CosmosID’s CLIA certified and GLP laboratory cover the entire workflow from study design to sample collection, extraction, library preparation, sequencing, data analysis and publication support. CosmosID’s cloud-based metagenomics application offers user-friendly access to the largest curated databases for microbial genomics, antimicrobial resistance and virulence data and has been independently validated to return metagenomic analyses at strain level resolution with industry-leading sensitivity and precision.